| 5) Liver cancer (a + b + c + d) | 433,845,232 |
| a) Liver cancer secondary to hepatitis B | 156,715,485 |
| b) Liver cancer secondary to hepatitis C | 172,860,632 |
| c) Liver cancer secondary to alcohol use | 56,236,348 |
| d) Other liver cancer | 48,032,767 |
| 6) Pancreas cancer | 522,483,156 |
| 7) Trachea, bronchus, lung cancers | 2,960,905,851 |
| 8) Melanoma and other skin cancers (a + b) | 154,115,139 |
| a) Malignant skin melanoma | 55,850,959 |
| b) Non-melanoma skin cancer | 98,264,180 |
| 9) Breast cancer | 3,157,446,478 |
| 10) Cervix uteri cancer | 668,446,851 |
| 11) Corpus uteri cancer | 85,735,228 |
| 12) Ovary cancer | 534,967,291 |
| 13) Prostate cancer | 570,432,436 |
| 14) Testicular cancer | 63,940,930 |
| 15) Kidney cancer | 465,095,805 |
| 16) Bladder cancer | 626,333,082 |
| 17) Brain and nervous system cancers | 1,135,054,537 |
| 18) Gallbladder and biliary tract cancer | 537,315,885 |
| 19) Larynx cancer | 297,671,696 |
| 20) Thyroid cancer | 290,949,234 |
| 21) Mesothelioma | 40,925,477 |
| 22) Lymphomas, multiple myeloma (a + b + c) | 1,815,703,029 |
| a) Hodgkin lymphoma | 432,192,940 |
| b) Non-Hodgkin lymphoma | 1,065,903,943 |
| c) Multiple myeloma | 317,606,146 |
| 23) Leukaemia | 1,390,480,541 |
| 24) Other malignant neoplasms | 2,947,752,833 |
| (B) Other neoplasms | 897,484,434 |
| (C) Diabetes mellitus | 17,544,290,025 |
| (D) Endocrine, blood, immune disorders (1 + 2 + 3 + 4) | 3,141,123,979 |
| 1) Thalassaemias | 1,103,334,653 |
| 2) Sickle cell disorders and trait | 297,471,875 |
| 3) Other haemoglobinopathies and haemolytic anaemias | 659,552,410 |
| 4) Other endocrine, blood and immune disorders | 1,080,765,040 |
| (E) Mental and substance use disorders (1 + 2 + 3 + … + 11) | 23,947,083,831 |